This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Astrazeneca Ab. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Jon Winter-holt: Innovator in Cancer Therapy
Introduction
Jon Winter-holt is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of cancer therapy through his innovative research and development of pharmaceutical compounds. His work focuses on the inhibition of DNA polymerase theta, which plays a crucial role in cancer treatment.
Latest Patents
Jon Winter-holt holds a patent for POLQ inhibitors. The specification generally relates to compounds of Formula (I) or a stereoisomer or pharmaceutically acceptable salt thereof. These compounds are particularly useful in the treatment of cancer as they inhibit the polymerase, DNA polymerase theta (Polθ or POLQ). The patent outlines the compositions containing these compounds and their therapeutic applications.
Career Highlights
Jon Winter-holt is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to collaborate with other experts in the field and contribute to groundbreaking research in cancer therapies.
Collaborations
One of his notable coworkers is Bernard Barlaam, with whom he has likely collaborated on various projects related to their research in cancer treatment.
Conclusion
Jon Winter-holt's innovative work in developing POLQ inhibitors represents a significant advancement in cancer therapy. His contributions continue to impact the field positively, showcasing the importance of research and innovation in medicine.